focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Regulatory News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

8 Nov 2019 10:54

RNS Number : 8051S
e-Therapeutics plc
08 November 2019
 

 

For filings with the FCA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i

 

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

E-Therapeutics plc

 

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

 

 

3. Full name of person(s) subject to the notification obligation: iii

Rupert Labrum

4. Full name of shareholder(s)

(if different from 3.): iv

5. Date of the transaction and date on which the threshold is crossed or reached: v

05/11/2019

6. Date on which issuer notified:

08/11/2019

7. Threshold(s) that is/are crossed or

reached: vi, vii

Less than 3.00%

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B2823H99

17162547

17162547

Less than 3%

Less than

3%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/ Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

Less than 3 %

Less than 3 %

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

14. Contact name:

 Rupert Labrum

15. Contact telephone number:

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLEAEFPESENFFF
Date   Source Headline
31st May 20182:13 pmRNSResults of Annual General Meeting
1st May 20187:00 amRNSCollaboration with C4X Discovery Holdings PLC
4th Apr 20184:13 pmRNSNotice of AGM
27th Mar 20187:00 amRNSFull Year Results
12th Mar 20187:00 amRNSNotification of Full Year Results Date
22nd Jan 20187:00 amRNSDirector/PDMR Shareholding
15th Jan 20187:00 amRNSE-Therapeutics enters two AI collaborations
3rd Jan 20187:00 amRNSDirector/PDMR Shareholding
18th Dec 20172:31 pmRNSHolding(s) in Company
18th Dec 20178:57 amRNSDirector/PDMR Shareholding
1st Nov 20177:00 amRNSAppointment of Director
5th Oct 201711:35 amEQSEdison issues update on e-Therapeutics (ETX)
26th Sep 20177:00 amRNSInterim Results for 6 Months Ended 31 July 2017
5th Sep 20179:41 amRNSNotice of Results
22nd Aug 20172:13 pmRNSDirector/PDMR Shareholding
27th Jul 20174:46 pmRNSEdison issues update on e-Therapeutics (ETX)
27th Jul 20173:24 pmEQSEdison Investment Research Limited: Edison issues update on e-Therapeutics (ETX)
24th Jul 20177:00 amRNSOutcome of Strategic Review and Future Plans
3rd Jul 20174:50 pmRNSDirector/PDMR Shareholding
19th Jun 201710:13 amRNSTR-1: Notification of Major Interest in Shares
5th Jun 20172:21 pmRNSTR-1: Notification of Major Interest in Shares
2nd Jun 20173:19 pmRNSTR-1: Notification of Major Interest in Shares
2nd Jun 20172:50 pmRNSTR-1: Notification of Major Interest in Shares
2nd Jun 201712:02 pmRNSTR-1: Notification of Major Interest in Shares
2nd Jun 20179:00 amRNSDirector/PDMR Shareholding
31st May 20172:01 pmRNSResults of Annual General Meeting
25th May 201711:20 amRNSNotification by Director
23rd May 20174:22 pmRNSDirector/PDMR Shareholding
8th May 20173:02 pmRNSNotice of Annual General Meeting and Annual Report
3rd May 20179:00 amRNSDirector/PDMR Shareholding
19th Apr 20177:00 amRNSFinal Results
6th Apr 20177:01 amRNSNotification of Full Year Results Date
6th Apr 20177:00 amRNSNew CEO Commences at e-Therapeutics
4th Apr 20178:30 amRNSHolding(s) in Company
4th Apr 20178:30 amRNSHolding(s) in Company
16th Feb 20177:00 amRNSDirectorate Change
12th Jan 201710:38 amRNSHolding(s) in Company
9th Jan 20177:00 amRNSAppointment of CEO
4th Jan 20177:00 amRNSDirector/PDMR Shareholding
23rd Nov 20164:21 pmRNSGrant of share options and Directors' dealings
6th Oct 201610:12 amRNSDirectors' Dealings and Issue of Equity
3rd Oct 20162:03 pmRNSFurther re: Directors' Shareholdings
21st Sep 20164:06 pmRNSIssue of Equity and Directors' shareholdings
20th Sep 20167:00 amRNSHalf year results
14th Sep 201612:08 pmRNSManagement Update
9th Sep 20169:30 amRNSNotice of Half Year Results
18th Aug 20165:07 pmRNSHolding(s) in Company - Correction
18th Aug 201611:07 amRNSHolding(s) in Company
1st Aug 20164:40 pmRNSIssue of Equity
13th Jul 201610:05 amRNSBoard changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.